News

Drug delivery company DelSiTech Ltd appoints a new CEO

Drug delivery company DelSiTech Ltd appoints a new CEO

DelSiTech ltd (info a delsitech.com), Jun 19th 2013

”DelSiTech is an exciting drug delivery technology company which is a global leader in its technology segment. The company and its technology have significant future business potential, and I’m very pleased to be part of this success story”

Finnish drug delivery technology company DelSiTech Ltd has appointed Lasse Leino, PhD, as company CEO starting from 1st June. Previously, Dr. Leino served as CEO and COO of the drug development company Laurantis Pharma Ltd. He is also the founder and long-term CEO of BioCis Pharma Ltd.

”DelSiTech is an exciting drug delivery technology company which is a global leader in its technology segment. The company and its technology have significant future business potential, and I’m very pleased to be part of this success story”, says Dr. Leino.

”We are extremely excited about Dr. Leino joining us. He has over 15 years international experience in management of drug development both in pharma and biotech industry, which opens new business opportunities for the company. Dr. Leino also brings a depth of business development and financing experience that will be a perfect complement to the current competence of the core team, says Dr. Harry Jalonen, former CEO of DelSiTech and a member of the company founder team. Dr. Jalonen will continue as Member of the Board of Directors and remains as Senior Advisor.



Back